Atea Pharmaceuticals, Inc. (AVIR)
Data as of , from SEC Form 4 filings.
No open-market insider trades (90d)Watch AVIR
See up to 3 months of AVIR. The 7-day demo opens the 1M and 3M ranges and puts AVIR on your watchlist.
Start 7-day demoLatest AVIR insider trades
Polly A. MurphyOpen-market purchase$25K- Polly A. MurphyOpen-market purchase$25K
- Franklin M. Berger
About Atea Pharmaceuticals, Inc. (AVIR)
Atea Pharmaceuticals, Inc. files with the SEC under CIK 0001593899 and is classified as pharmaceutical preparations. It is grouped with Health Care companies on this site.
AVIR Form 4 activity by transaction type, last 90 days
No Form 4 activity for AVIR in the last 90 days.
AVIR insider transactions (Form 4)
6819 Form 4 filings on record, the earliest from Dec 12, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bruno Lucidi | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| Bruno Lucidi | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Bruno Lucidi | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| Bruno Lucidi | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| ||||||
| Franklin M. Berger | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Franklin M. Berger | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| Franklin M. Berger | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Franklin M. Berger | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| ||||||
| Howard Berman | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| Howard Berman | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Barbara Gayle Duncan | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Barbara Gayle Duncan | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| Barbara Gayle Duncan | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Barbara Gayle Duncan | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| ||||||
| Bruce Polsky | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Bruce Polsky | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| Bruce Polsky | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Bruce Polsky | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| ||||||
| Polly A. Murphy | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Polly A. Murphy | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| Polly A. Murphy | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Polly A. Murphy | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| ||||||
| Jerome M. Adams | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| Jerome M. Adams | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Jerome M. Adams | Option exercise | Common Stock | 29,600 | $0.00 footnote F1 | - | |
| Jerome M. Adams | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| ||||||
| Arthur S. Kirsch | Grant or award | Restricted Stock Units | 26,700 | $0.00 | - | |
| Arthur S. Kirsch | Grant or award | Stock Option (Right to Buy) | 37,700 | $0.00 | - | |
| Polly A. Murphy | Open-market purchase | Common Stock | 6,100 | $4.17 | $25K | |
| Polly A. Murphy | Open-market purchase | Common Stock | 6,100 | $4.17 footnote F1 | $25K | |
| ||||||
 Andrea Corcoran - Officer | Option exercise | Common Stock | 60,000 | $1.24 | $74K | |
| Andrea Corcoran - Officer | Option exercise | Stock Option (Right to Buy) | 60,000 | $0.00 | - | |
| Maria Arantxa Horga - Officer | Tax withholding / forfeiture | Common Stock | 16,073 | $4.24 | $68K | |
| Maria Arantxa Horga - Officer | Option exercise | Common Stock | 51,283 | - footnote F1 | - | |
| Maria Arantxa Horga - Officer | Option exercise | Restricted Stock Units | 41,533 | $0.00 | - | |
| Maria Arantxa Horga - Officer | Option exercise | Restricted Stock Units | 9,750 | $0.00 | - | |
| Maria Arantxa Horga - Officer | Grant or award | Stock Option (Right to Buy) | 173,500 | $0.00 | - | |
| ||||||
 John Vavricka - Officer | Tax withholding / forfeiture | Common Stock | 11,570 | $4.24 | $49K | |
| John Vavricka - Officer | Option exercise | Common Stock | 42,083 | - footnote F1 | - | |
| John Vavricka - Officer | Option exercise | Restricted Stock Units | 33,333 | $0.00 | - | |
| John Vavricka - Officer | Option exercise | Restricted Stock Units | 8,750 | $0.00 | - | |
| John Vavricka - Officer | Grant or award | Stock Option (Right to Buy) | 119,520 | $0.00 | - | |
| ||||||
 Janet Mj Hammond - Officer | Tax withholding / forfeiture | Common Stock | 14,136 | $4.24 | $60K | |
| Janet Mj Hammond - Officer | Option exercise | Common Stock | 58,050 | - footnote F1 | - | |
| Janet Mj Hammond - Officer | Option exercise | Restricted Stock Units | 46,800 | $0.00 | - | |
| Janet Mj Hammond - Officer | Option exercise | Restricted Stock Units | 11,250 | $0.00 | - | |
| Janet Mj Hammond - Officer | Grant or award | Stock Option (Right to Buy) | 177,000 | $0.00 | - | |
| ||||||
| Andrea Corcoran - Officer | Tax withholding / forfeiture | Common Stock | 16,104 | $4.24 | $68K | |
| Andrea Corcoran - Officer | Option exercise | Common Stock | 54,866 | - footnote F1 | - | |
| Andrea Corcoran - Officer | Option exercise | Restricted Stock Units | 44,366 | $0.00 | - | |
| Andrea Corcoran - Officer | Option exercise | Restricted Stock Units | 10,500 | $0.00 | - | |
| Andrea Corcoran - Officer | Grant or award | Stock Option (Right to Buy) | 180,000 | $0.00 | - | |
| ||||||
| Jean-Pierre Sommadossi - Officer | Tax withholding / forfeiture | Common Stock | 106,093 | $4.24 | $450K | |
| Jean-Pierre Sommadossi - Officer | Option exercise | Common Stock | 300,000 | $1.24 | $372K | |
| Jean-Pierre Sommadossi - Officer | Option exercise | Common Stock | 272,983 | - footnote F1 | - | |
| Jean-Pierre Sommadossi - Officer | Option exercise | Restricted Stock Units | 173,466 | $0.00 | - | |
| Jean-Pierre Sommadossi - Officer | Option exercise | Restricted Stock Units | 99,517 footnote F4 | $0.00 | - | |
| Jean-Pierre Sommadossi - Officer | Option exercise | Stock Option (Right to Buy) | 300,000 | $0.00 | - | |
| ||||||
 Wayne Foster - Officer | Tax withholding / forfeiture | Common Stock | 12,132 | $4.24 | $51K | |
| Wayne Foster - Officer | Option exercise | Common Stock | 41,333 | - footnote F1 | - | |
| Wayne Foster - Officer | Option exercise | Restricted Stock Units | 33,333 | $0.00 | - | |
| Wayne Foster - Officer | Option exercise | Restricted Stock Units | 8,000 | $0.00 | - | |
| Wayne Foster - Officer | Grant or award | Stock Option (Right to Buy) | 108,000 | $0.00 | - | |
| ||||||
| Franklin M. Berger | Option exercise | Common Stock | 29,600 | $0.00 | - | |
| Franklin M. Berger | Grant or award | Restricted Stock Units | 29,600 | $0.00 | - | |
| Franklin M. Berger | Grant or award | Stock Option (Right to Buy) | 41,200 | $0.00 | - | |
| Franklin M. Berger | Option exercise | Restricted Stock Units | 29,600 | $0.00 | - | |
| Franklin M. Berger | Open-market sale | Common Stock | 359,606 | $2.85 | $1.02M | |
Item 2.02, 9.01
Item 5.07
Item 2.02, 9.01
Item 2.02, 9.01
AVIR insider trading FAQ
What is the latest insider trade for AVIR?
Atea Pharmaceuticals, Inc. (AVIR) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-23. The full record for AVIR runs to 19 Form 4 filings, the earliest from 2024-12-12. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AVIR stock?
No insider purchases of AVIR were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling AVIR stock?
No insider sales of AVIR were filed in the last 90 days. 1 sale is on record for this company.
Where can I see AVIR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AVIR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Bruno Lucidi view on EDGAR
- - Franklin M. Berger view on EDGAR
- - Howard Berman view on EDGAR
- - Barbara Gayle Duncan view on EDGAR
- - Bruce Polsky view on EDGAR
- - Polly A. Murphy view on EDGAR
- - Jerome M. Adams view on EDGAR
- - Arthur S. Kirsch view on EDGAR
- - Polly A. Murphy view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where AVIR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AVIR with a 7-day demo
- AVIR on your watchlist
- Every AVIR Form 4 filing on record
- Up to 3 months of AVIR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
